These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

67 related items for PubMed ID: 1695002

  • 21. Cyclophosphamide, doxorubicin, and vincristine in etoposide- and cisplatin-resistant small cell lung cancer.
    Shepherd FA, Evans WK, MacCormick R, Feld R, Yau JC.
    Cancer Treat Rep; 1987 Oct; 71(10):941-4. PubMed ID: 2820571
    [Abstract] [Full Text] [Related]

  • 22. [Adriamycin, cisplatin, and etoposide combination chemotherapy for small cell lung cancer].
    Irino S, Fujita J, Yamaji Y, Futami H, Hashimoto Y, Bungo M, Iuchi Y, Kamei M, Nakamura H, Hata Y.
    Gan To Kagaku Ryoho; 1989 Jun; 16(6):2263-7. PubMed ID: 2544150
    [Abstract] [Full Text] [Related]

  • 23. Chemotherapy with vincristine/ifosfamide/carboplatin/etoposide in small cell lung cancer.
    Lorigan P, Lee SM, Betticher D, Woodhead M, Weir D, Hanley S, Hardy C, Thatcher N.
    Semin Oncol; 1995 Jun; 22(3 Suppl 7):32-41. PubMed ID: 7610397
    [Abstract] [Full Text] [Related]

  • 24. No response improvement after sequential chemotherapy for small cell lung cancer.
    Postmus PE, Sleijfer DT, Meinesz AF, Kerstjens HA, Lo GT, Sluiter HJ.
    Eur J Respir Dis; 1986 Apr; 68(4):279-85. PubMed ID: 3015648
    [Abstract] [Full Text] [Related]

  • 25. Etoposide plus ifosfamide plus cisplatin in the treatment of small cell lung cancer.
    Sandler AB.
    Semin Oncol; 1998 Feb; 25(1 Suppl 2):38-41. PubMed ID: 9535210
    [Abstract] [Full Text] [Related]

  • 26. [A combination chemotherapy of cisplatin and etoposide in small cell lung cancer].
    Saito R, Tsuchiya S, Minato K, Ishizuka T.
    Nihon Gan Chiryo Gakkai Shi; 1988 Mar 20; 23(3):744-51. PubMed ID: 2841389
    [No Abstract] [Full Text] [Related]

  • 27. Phase II trial of postoperative adjuvant cisplatin and etoposide in patients with completely resected stage I-IIIa small cell lung cancer: the Japan Clinical Oncology Lung Cancer Study Group Trial (JCOG9101).
    Tsuchiya R, Suzuki K, Ichinose Y, Watanabe Y, Yasumitsu T, Ishizuka N, Kato H.
    J Thorac Cardiovasc Surg; 2005 May 20; 129(5):977-83. PubMed ID: 15867769
    [Abstract] [Full Text] [Related]

  • 28. [Small cell lung cancer: a retrospective analysis of results of chemotherapy and combined modality treatment].
    Ohnoshi T, Hiraki S, Ueoka H, Kawahara S, Numata T, Nishii K, Yonei T, Yamashta H, Kiura K, Kozuka A.
    Gan To Kagaku Ryoho; 1989 Apr 20; 16(4 Pt 2-2):1341-8. PubMed ID: 2543304
    [Abstract] [Full Text] [Related]

  • 29. Addition of etoposide to cyclophosphamide, doxorubicin, and vincristine for remission induction and survival in patients with small cell lung cancer.
    Messeih AA, Schweitzer JM, Lipton A, Harvey HA, Simmonds MA, Stryker JA, Ricci JA, Hoffman SL, Gottleib RJ, Dixon RH.
    Cancer Treat Rep; 1987 Jan 20; 71(1):61-6. PubMed ID: 3024828
    [Abstract] [Full Text] [Related]

  • 30. Comparison of cisplatin-paclitaxel combination versus cisplatin-etoposide in patients with small-cell lung cancer: a Phase III study.
    Dimitroulis J, Rapti A, Stathopoulos GP, Rigatos S, Stathopoulos J, Koutantos J, Athanasiadis A, Tsikritsaki K, Karaindros D, Katis K, Antoniou D, Toumbis M, Giamboudakis P.
    Oncol Rep; 2008 Oct 20; 20(4):879-84. PubMed ID: 18813830
    [Abstract] [Full Text] [Related]

  • 31. Etoposide (VP-16) containing combination chemotherapy for treatment of patients with small cell lung cancer.
    Behera D, Jindal SK, Sharma SC.
    Indian J Chest Dis Allied Sci; 1995 Oct 20; 37(1):15-9. PubMed ID: 16892733
    [Abstract] [Full Text] [Related]

  • 32. Experience of a German multicenter study group with ifosfamide in small cell lung cancer.
    Havemann K, Wolf M, Drings P, Hans K, Schroeder M, Holle R, Flechtner H, Goerg R, Becker H.
    Semin Oncol; 1989 Feb 20; 16(1 Suppl 3):9-18. PubMed ID: 2539648
    [Abstract] [Full Text] [Related]

  • 33. [Therapeutic results in the treatment of small cell bronchial cancer: experience of the EORTC Lung Cancer Working Party (Belgium)].
    Sculier JP.
    Bull Cancer; 1987 Feb 20; 74(5):565-8. PubMed ID: 2825858
    [Abstract] [Full Text] [Related]

  • 34. A randomized trial of hybrid administration of cyclophosphamide, doxorubicin, and vincristine (CAV)/cisplatin and etoposide (PVP) versus sequential administration of CAV-PVP for the treatment of patients with small cell lung carcinoma: results of long term follow-up.
    Ueoka H, Kiura K, Tabata M, Kamei H, Gemba K, Sakae K, Hiraki Y, Hiraki S, Segawa Y, Harada M.
    Cancer; 1998 Jul 15; 83(2):283-90. PubMed ID: 9669811
    [Abstract] [Full Text] [Related]

  • 35. Pilot study with weekly chemotherapy for patients with extensive small cell lung cancer: an Eastern Cooperative Oncology Group Study (PA586).
    Yuen AR, Fuks JZ, Ettinger DS, Chang AY, Ruckdeschel JC, Phan SC, Blum RH.
    Cancer J Sci Am; 2000 Jul 15; 6(1):34-9. PubMed ID: 10696737
    [Abstract] [Full Text] [Related]

  • 36. Vincristine and etoposide: an effective chemotherapy regimen with reduced toxicity in extensive small-cell lung cancer.
    Morgan DA, Gilson D, Fletcher J.
    Eur J Cancer Clin Oncol; 1987 Jun 15; 23(6):619-21. PubMed ID: 2820741
    [Abstract] [Full Text] [Related]

  • 37. [Phase II study of etoposide in patients with lung cancer, with special reference to small cell carcinoma].
    Kurita Y, Yokoyama A, Kinameri K, Matsuura N, Sano K.
    Nihon Gan Chiryo Gakkai Shi; 1986 Feb 20; 21(1):108-11. PubMed ID: 3009665
    [No Abstract] [Full Text] [Related]

  • 38. [EPICO in the treatment of small cell bronchial cancer. 3. Intermediate analysis].
    Drings P, Bülzebruck H, Hruska D, Manke HG, Schuler G.
    Onkologie; 1986 Aug 20; 9 Suppl 1():14-20. PubMed ID: 3018648
    [Abstract] [Full Text] [Related]

  • 39. Combination chemotherapy for extensive small cell lung cancer -- experience from India.
    Behera D, Aggarwal AN, Sharma SC, Gupta D, Jindal SK.
    Lung Cancer; 2001 May 20; 32(2):207-8. PubMed ID: 11396415
    [No Abstract] [Full Text] [Related]

  • 40. Phase I trial of granulocyte-macrophage colony-stimulating factor with high-dose cisplatin and etoposide for treatment of small-cell lung cancer: a study of the National Cancer Institute of Canada Clinical Trials Group.
    Shepherd FA, Goss PE, Rusthoven J, Eisenhauer EA.
    J Natl Cancer Inst; 1992 Jan 01; 84(1):59-60. PubMed ID: 1310748
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 4.